Home » Stocks » SONN

Sonnet BioTherapeutics Holdings, Inc. (SONN)

Stock Price: $2.01 USD -0.02 (-0.99%)
Updated Apr 22, 2021 4:00 PM EDT - Market closed
After-hours: $2.05 +0.04 (1.99%) Apr 22, 7:50 PM
Market Cap 35.81M
Revenue (ttm) 5.68M
Net Income (ttm) -68.47M
Shares Out 17.22M
EPS (ttm) -10.38
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day April 22
Last Price $2.01
Previous Close $2.03
Change ($) -0.02
Change (%) -0.99%
Day's Open 2.04
Day's Range 1.99 - 2.09
Day's Volume 441,735
52-Week Range 1.81 - 7.89

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

PRINCETON, NJ / ACCESSWIRE / March 29, 2021 / Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) ("Sonnet" or the "Company"), a biopharmaceutical company developing innovative targeted biologic drugs, ...

3 weeks ago - Accesswire

PRINCETON, NJ / ACCESSWIRE / March 22, 2021 / Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) ("Sonnet" or the "Company"), a biopharmaceutical company developing innovative targeted biologic drugs, ...

1 month ago - Accesswire

Wall Street recommends buying shares of Sonnet BioTherapeutics Holdings Inc. (NASDAQ:SONN) and Sigma Labs Inc. (NASDAQ:SGLB), which you would not expect after these 2 stocks performed so poorly over the...

Other stocks mentioned: SGLB
4 months ago - GuruFocus

PRINCETON, NJ / ACCESSWIRE / December 17, 2020 / Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) ("Sonnet" or the "Company"), a biopharmaceutical company developing innovative targeted biologic drug...

4 months ago - Accesswire

The pandemic highlights how far medical science has come. It also highlights how exciting the future is.

Other stocks mentioned: ADMA, AZN, BNTX, CERS, LMNL, PFE
7 months ago - InvestorPlace

Health care stocks levered to blood collection and sampling, and plasma therapy biopharma companies are getting a big boost Monday after the FDA issued emergency use authorization for the use of investi...

Other stocks mentioned: ADMA, CERS, GRFS, KMDA, LMNL, THMO, TTOO
7 months ago - Benzinga

The U.S. Food and Drug Administration issued an emergency use authorization (EUA) for investigational convalescent plasma for the treatment of COVID-19 in hospitalized patients as part of the agency’s o...

Other stocks mentioned: KMDA, LMNL
7 months ago - Benzinga

Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) were down 11% on Wednesday after skyrocketing 56.9% on Tuesday on COVID-19-related news.

1 year ago - Benzinga

About SONN

Sonnet BioTherapeutics Holdings, Inc., an oncology-focused biotechnology company, develops platform for biologic medicines of single or bispecific action. The company develops fully human albumin binding (FHAB) technology, which utilizes human single chain antibodies fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. Its lead candidate includes SON-080, a human version of low dose Interleukin-6 (IL-6), which has completed Phase I trials for the treatment of patients with chemotherapy-induced periphera... [Read more...]

Industry
Biotechnology
CEO
Michael Pruitt
Employees
9
Stock Exchange
NASDAQ
Ticker Symbol
SONN
Full Company Profile

Financial Performance

Financial Statements